Lactulose: A Simple Sugar in a Complex Encephalopathy

被引：3
作者：
Wijdicks, Eelco F. M. [1 ]
机构：
[1] Mayo Clin, Div Crit Care Neurol, 200 First St SW, Rochester, MN 55905 USA
来源：
NEUROCRITICAL CARE | 2018年 / 28卷 / 02期
关键词：
Lactulose; Hepatic encephalopathy; Portal-systemic encephalopathy; Ammonia; Johannes Bircher; PORTAL-SYSTEMIC ENCEPHALOPATHY; HEPATIC-ENCEPHALOPATHY; CEREBRAL EDEMA; NEOMYCIN; TRIAL;
D O I：
10.1007/s12028-017-0494-4
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Hepatic encephalopathy is a common encephalopathy and one of the very few that are treatable. Lactulose has remained a standard pharmaceutical intervention and is listed as one of the World Health Organization's Essential Medicines. The discovery of lactulose, the acid dialysis proof of concept, and the role of Bircher are not well known. This historical vignette reviews the gradual understanding of the complex liver-brain connection, the effective treatment of hepatic stupor with lactulose, and the immediate relevance of lactulose to the practice of consultative neurocritical care.
引用
收藏
页码：154 / 156
页数：3
相关论文
共 50 条
  • [21] Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy
    Singh, Jatinderpal
    Sharma, Barjesh Chander
    Puri, Vinod
    Sachdeva, Sanjeev
    Srivastava, Siddharth
    METABOLIC BRAIN DISEASE, 2017, 32 (02) : 595 - 605
  • [22] THE ROLE OF LACTULOSE FOR THE PROPHYLAXIS OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH ACUTE VARICEAL BLEED
    Hussain, Sabir
    Iqbal, Mujahid
    Abbas, Huda
    Hussain, Wajahat
    Imran, Muhammad
    Irshad, Muzammil
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (03): : 5396 - 5402
  • [23] Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy
    Leevy, Carroll B.
    Phillips, James A.
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (03) : 737 - 741
  • [24] EFFECT OF USING LACTULOSE AND RIFAXIMIN IN COMPARISON WITH LACTULOSE ONLY THERAPY IN TREATEMENT OF HEPATIC ENCEPHALOPATHY: A RANDOMIZED CONTROLLED TRIAL.
    Akbar, Muneeba
    Jabeen, Moqadsa
    Nayyer, Faiqua
    Maryam
    Sardar, Usama
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (05): : 3259 - 3262
  • [25] Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: An open labeled randomized controlled trial of lactulose versus no lactulose
    Sharma, Praveen
    Sharma, Barjesh Chander
    Agrawal, Amit
    Sarin, Shiv Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (08) : 1329 - 1335
  • [26] Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: A prospective randomized study
    Paik, YH
    Lee, KS
    Han, KH
    Song, KH
    Kim, MH
    Moon, BS
    Ahn, SH
    Lee, SJ
    Park, HJ
    Lee, DK
    Chon, CY
    Lee, SI
    Moon, YM
    YONSEI MEDICAL JOURNAL, 2005, 46 (03) : 399 - 407
  • [27] Lactulose enhances neuroplasticity to improve cognitive function in early hepatic encephalopathy
    Nan Yang
    He Liu
    Yao Jiang
    Ji Zheng
    Dong-mei Li
    Chao Ji
    Yan-yong Liu
    Ping-ping Zuo
    NeuralRegenerationResearch, 2015, 10 (09) : 1457 - 1462
  • [28] Hospitalizations During the Use of Rifaximin Versus Lactulose for the Treatment of Hepatic Encephalopathy
    Carroll B. Leevy
    James A. Phillips
    Digestive Diseases and Sciences, 2007, 52 : 737 - 741
  • [29] A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy
    Sharma, Barjesh Chander
    Sharma, Praveen
    Lunia, Manish Kumar
    Srivastava, Siddharth
    Goyal, Rohit
    Sarin, S. K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (09) : 1458 - 1463
  • [30] Efficacy of lactulose in the prophylaxis of hepatic encephalopathy in cirrhotic patients presenting gastrointestinal bleeding
    Aires, Felipe Toyama
    Ramos, Paola Teruya
    Bernardo, Wanderley Marques
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2016, 62 (03): : 243 - 247
12345